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Introduction: Myeloid sarcoma is a rare extramedullary malignant tumor composed of immature myeloid cells.
The tumor can affect any part of the body. Involvement of the oral cavity and nasopharynx has been reported in
50 cases. We report a case describing myeloid sarcoma affecting the lateral pharyngeal wall.
Case presentation: A 31-year-old Arabian man who had acute biphenotypic leukemia treated with chemoradiation
and allogeneic stem cell transplant was referred to our department with sore throat and a mass lesion in his lateral
pharyngeal wall after failed antibiotic therapy. Biopsy of his lesion revealed myeloid sarcoma. He was referred to the
Department of Hematology-Oncology for further evaluation that showed no other lesions.
The patient was diagnosed with isolated extramedullary myeloid sarcoma of his lateral pharyngeal wall as a relapse
of acute biphenotypic leukemia and managed with chemoradiation.
Conclusions: Myeloid sarcoma of the pharynx is a rarely encountered malignancy in the practice of
otolaryngology-head and neck surgery. It can develop de novo, but may also represent relapse of leukemia. Thus, it
should be considered in the differential diagnosis of any pharyngeal lesions in patients with leukemia.
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Myeloid sarcoma (MS) is a rare extramedullary malig-
nant tumor composed of immature myeloid cells. Burns
first described the lesion in 1811 [1] and King first used
the term chloroma in 1853 because the tumor often ex-
hibits a greenish color on exposure to air, owing to the
presence of myeloperoxidase in the tumor cells [2]. Dock
described the relationship between acute myeloid leu-
kemia (AML) and granulocytic sarcoma in 1893 [3].
Rappaport used the term “granulocytic sarcoma” because
microscopically the tumor is composed of immature
granulocytic cells and resembles a sarcoma [4].
MS is often discovered concomitantly or subsequently
to previously diagnosed AML. It can also be found as an
isolated lesion or may precede the disease in the bone
marrow [5]. We present a case of a 31-year-old Arabian* Correspondence: ra_rumaih@yahoo.com
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reproduction in any medium, provided the orman who presented with a lateral pharyngeal wall mass
diagnosed as an isolated extramedullary MS and as a re-
lapse of acute biphenotypic leukemia 4 years after allo-
geneic stem cell transplant (ASCT).
Case presentation
A 31-year-old Arabian man, diagnosed with acute bi-
phenotypic leukemia and treated with chemoradiation
followed by ASCT 4 years previously, was referred from
the Department of Hematology-Oncology. He had a
1-month history of sore throat not responding to two
courses of oral antibiotics. His sore throat was not asso-
ciated with fever, upper respiratory tract infection symp-
toms, chills, rigor, fatigue or weight loss. His medical
history was significant for recently diagnosed and con-
trolled essential hypertension, treated hepatitis B infection,
and treated mucormycosis of the mandible encountered
during the course of ASCT.
On examination, he was in good general health. An
oropharyngeal examination revealed a 3×2cm granularal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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midline and pushing the uvula to the contralateral side
(Figure 1). It resembled a unilateral tonsillar enlarge-
ment with a normal contralateral tonsil. The rest of
the ears, nose and throat examination, including exa-
mination of his post-nasal space and larynx, did not
reveal any abnormality. There was no cervical or sys-
temic lymphadenopathy. The systemic examination was
unremarkable.
A complete blood count showed normal hemoglobin
level and normal platelet and white cell counts. The co-
agulation profile, liver enzymes and electrolytes were all
within normal limits. An iodinated, contrast-enhanced
computed tomography (CT) scan of his head and neck
showed right tonsillar enlargement (2.7×2.3cm; Figure 2).
Apart from this, the CT scan did not show any other ab-
normalities or localized collections. There was no sign of
enlarged lymph nodes.
In view of the history of leukemia, a tonsillectomy was
carried out after taking informed consent. Intraopera-
tively, the mass was found to arise from the right lateral
pharyngeal wall, obscuring a normal-appearing right ton-
sil. There was no surgical plane between the mass and the
lateral pharyngeal wall. Because of the friability of the
mass, the majority of the tumor was removed in a piece-
meal fashion. Bleeding was minimal. Postoperative reco-
very was uneventful.Figure 1 Clinical photo showing granular mass arising from the rig
contralateral side.Microscopic examination revealed effacement of the
subepithelial tissue by infiltrating small, round blue cells,
with some starry sky appearance in the background due
to scattered large foamy macrophages (Figure 3A). The
infiltrating neoplasm rarely shows early differentiation
with evident eosinophilic precursors (Figure 3B). The
tumor cells were positive for CD117 (Figure 4), CD34
(Figure 5), myeloperoxidase (Figure 6) and lysozyme,
while negative for CD20, CD3, terminal deoxynucleoti-
dyl transferase, CD99 and cytokeratin. A portion of the
fresh tissue was also sent for flow cytometric evaluation,
which showed a dominant myeloid phenotype and po-
sitivity for CD45, CD34 (dim), CD117, CD33, CD13
(dim), CD7, CD38 and human leukocyte antigen-DR. T-
lymphoid-associated or B-cell antigens were not detected.
The patient was referred back to the Hematology-
Oncology Department for further evaluation and de-
finitive treatment of MS. Further work-up, including
diagnostic lumbar puncture and bone marrow biopsy,
were negative for leukemia. A gadolinium-enhanced mag-
netic resonance imaging scan of his brain and spine as
well as an abdominal ultrasound found no abnormalities
consistent with disseminated disease. No clonal chromo-
somal abnormalities were found from a chromosomal
analysis.
We made the diagnosis of an isolated extramedullary
MS of the lateral pharyngeal wall as a relapse of acuteht lateral pharyngeal wall and pushing the uvula to the
Figure 2 Iodinated, contrast-enhanced computed tomography scan of the head and neck (cross-section) showing non-enhancing,
homogenous enlargement of the right tonsil.
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departmental interdisciplinary tumor board and the de-
cision was made to treat the patient with chemoradia-
tion. He received five cycles of chemotherapy using
cytarabine and fludarabine as well as radiation treat-
ment using 1500cGy in five fractions to his throat. A
CT scan of his head and neck 1 month after comple-
tion of chemoradiation showed complete resolution of
the pharyngeal mass (Figure 7). The patient was un-
der the regular surveillance protocol by the Departments
of Hematology-Oncology and Otolaryngology at the time
of writing.
Discussion
MS is a well-known entity to the hematologist. However,
it is rarely encountered in otolaryngology practice. The
tumor can affect any part of the body. The commonly
involved sites include subperiosteal bone, lymph nodes
and skin [6]. The head and neck region is affected in
12% to 43% of cases [7]. Oral involvement is rare andonly 37 cases have been described between 1883 and
2008 [8]. We found an additional 10 cases in the English
literature from 2009 to March 2013 (Table 1). The pa-
late, tongue, upper and lower alveolus, buccal mucosa,
lips, tonsils and periapical region have all been affected.
In addition, we found three cases affecting the nasopha-
rynx and our case describes MS affecting the lateral
pharyngeal wall (Table 2).
MS can be encountered either as an isolated lesion
or during a course of AML, chronic myeloid leuke-
mia, myelodysplastic syndrome or myeloproliferative
disorders. It might be detected during the initial diag-
nosis of these diseases, present during the relapse or
be the first sign of relapse itself [5,21,22]. Isolated le-
sions, occurring in 8% to 20% of cases, appear to be
more common in the relapse of ASTC patients [23].
The reason for this association is still unknown, but
could be attributed to a pattern of graft-versus-leukemia
surveillance or the biology of high-risk AML treated with
transplantation [24].
Figure 3 Hematoxylin and eosin stained sections of the lesion.
(A) Low-power section showing subepithelial diffuse infiltrate of
small blue cells with starry sky appearance. (B) High-power section
showing myeloblasts with evident eosinophil precursors.
Figure 4 CD117.
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lenging, especially if not preceded by leukemia or other
bone marrow disease. In general, in any patient who pre-
sents with a non-infective unilateral pharyngeal wall le-
sion, malignancy should always be ruled out. In our
case, the appearance of a unilateral pharyngeal mass not
responding to medical treatment immediately raised the
suspicion of malignancy, especially in view of the pa-
tient’s hematological history. The differential diagnoses
generally include lymphoma, squamous cell carcinoma
and relapse of acute leukemia.
On histologic examination, MS shows variable mor-
phology. It can present with infiltration of cells at all
stages of myeloid differentiation; hence, it can be easily
recognized by the presence of eosinophilic myelocytes.
However, it can present with blastic cells with little or
no granulocytic differentiation, making it difficult to
diagnose by hematoxylin and eosin staining. Thus, it can
occasionally be difficult to differentiate MS from extra-
medullary hematopoiesis or other neoplasms such as
lymphoma, undifferentiated small round cell tumor and
malignant melanoma. Immunohistochemistry is help-
ful in such cases [25]. In our case, the presence of
eosinophilic precursors was a very helpful feature and
the morphology was very suggestive of the diagnosis.
This was confirmed by immunohistochemistry and flow
cytometry.
Because of the lack of randomized prospective studies,
there is no consensus on the treatment of MS. The
current recommended treatment regimen is similar to
the conventional AML chemotherapeutic protocols. The
Figure 5 CD34.
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though it is often given [26-28].
Owing to the rarity of MS, randomized controlled tri-
als to address prognostic factors are difficult to perform.
Overall, there seems to be a difference in prognosis
between MS patients presenting with an isolated le-
sion compared with those who have concomitant leu-
kemia or relapse. The latter have a poorer outcome
and shorter survival [26]. In terms of specific prognos-
tic factors, Pileri and colleagues analyzed 92 patientsFigure 6 Myeloperoxidase.with MS and found that disease course and response to
therapy were not influenced by patients’ age, gender,
anatomic location, clinical presentation, previous clini-
cal history, morphological classification, immunopheno-
type and cytogenetic findings [25].
Conclusions
MS of the pharynx is a rarely encountered malignancy in
the practice of otolaryngology-head and neck surgery. It
can develop de novo but may also represent relapse of
Figure 7 Computed tomography scan of the head and neck (cross-section) after chemoradiation showing resolution of the lesion.
Table 1 Summary of reported cases of intraoral myeloid
sarcoma from 2009 to March 2013





King Kim et al. [9] 2009 4/F AML* Mandible
Tuntiwong and
Kiatmanakul [10]
2009 16/F De novo Mandible
Cheng et al. [11] 2009 56/M AML relapse Buccal
mucosa
Osterne et al. [8] 2009 23/F AML relapse Mandible
da Silva-Santos et al. [12] 2010 47/F CML relapse Gingiva
Fasanmade et al. [13] 2010 75/F MDS Mandible
Papamanthos et al. [14] 2010 72/F AML Mandible
Cheng et al. [15] 2011 57/M MDS Tonsil
Dym and Movahed [16] 2011 16/F AML relapse Palate
Seema et al. [17] 2011 5/M De novo Mandible
Abbreviations: AML acute myeloid leukemia, CML chronic myeloid leukemia,
F Female, M Male, MDS myelodysplastic disorders; *Myeloid sarcoma was the
presenting lesion.
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tial diagnosis of any pharyngeal lesions in patients with
leukemia.Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.Table 2 Summary of reported cases of pharyngeal
myeloid sarcoma





Sugimoto et al. [18] 2004 31/F AML relapse Nasopharynx
Selvarajan et al. [19] 2008 25/M AML relapse Nasopharynx
Cho et al. [20] 2011 18/M De novo Nasopharynx




Abbreviations: AML acute myeloid leukemia, F Female, M Male.
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